All posts by: Michael Zand

About Michael Zand

FDA advisers urge approval for first gene therapy for inherited … – Washington Post

Continue reading

2017-10-12 NEWS

Washington Post

Continue reading

2017-10-12 NEWS

NBCNews.com

FDA Panel Advises Approval of Gene Therapy for Blinding Disease
NBCNews.com
Misty Lovelace of Alexandria, Kentucky, had never clearly seen her mother’s face. She’d never seen stars. But all that changed when the 18-year-old got an experimental gene therapy treatment that not only stopped her from going blind, but gave her back …
FDA advisers urge approval for first gene therapy for inherited diseaseWashington Post
FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review
Accessibility linksNPR
Futurism –Newsweek –Barron’s
all 47 news articles »
Continue reading

2017-10-12 NEWS

Nature.com

FDA advisers back gene therapy for rare form of blindness
Nature.com
Advisers to the US Food and Drug Administration (FDA) have paved the way for the agency’s first approval of a gene therapy to treat a disease caused by a genetic mutation. On 12 October, a panel of external experts unanimously voted that the benefits
FDA advisers urge approval for first gene therapy for inherited diseaseWashington Post
FDA Panel Advises Approval of Gene Therapy for Blinding DiseaseNBCNews.com
FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review
Science Magazine –New England Journal of Medicine –The Lancet –OHSU
all 172 news articles »
Continue reading

2017-10-12 NEWS

Business Insider

A first-of-its-kind treatment for blindness just got one step closer to approval
Business Insider
Gene therapy hereditary blindness eye exam In this Oct. 4, 2017 photo, Dr. Albert Maguire checks the eyes of Misa Kaabali, 8, at the Children’s Hospital of Philadelphia. Misa was 4 years old when he received his gene therapy treatment. AP. A US Food

and more »